Short answer
Beauty Health Co (SKIN) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $71M (down 10.3% year over year) with net income of −$11M.
Q3 2025 key financials · XBRL
- Revenue
- $71M
- −10.3% YoY · −9.6% QoQ
- Net income
- −$11M
- +39.7% YoY · −156.0% QoQ
- Operating margin
- -8.8%
- Gross margin
- 64.6%
- EPS (diluted)
- −$0.09
- +18.2% YoY · −250.0% QoQ
Source: XBRL data from the Beauty Health Co (SKIN) Q3 2025 10-Q on SEC EDGAR. USD.
Beauty Health Co Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $70.7M, down 10.3% YoY from $78.8M
- Gross margin 64.6% vs 51.6% YoY; operating loss margin 8.8% vs 27.3%
- Best line Consumables $49.8M, down 2.6%; worst Delivery Systems $20.8M, down 24.6%
- Cash, cash equivalents, and restricted cash $219.4M at September 30, 2025
- Headwinds: macroeconomic and credit conditions, tariffs, supply constraints, older Syndeo issues, and China distributor transition
Risk Factors
- Newly added financing risk: 7.95% Convertible Senior Secured Notes due 2028 introduced restrictive covenants
- Most material update: 2028 Indenture limits additional debt, liens, investments, restricted payments, acquisitions, dividends, and repurchases
- Compliance risk: covenant breach under the 2028 Notes would constitute an event of default
- Financial risk: Restrictions may limit future debt financing and capital-raising flexibility
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Beauty Health Co quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.